Addex Therapeutics (ADXN) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$447.8 million.
- Addex Therapeutics' Retained Earnings fell 1018.1% to -$447.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$447.8 million, marking a year-over-year decrease of 1018.1%. This contributed to the annual value of -$401.7 million for FY2024, which is 9.03% down from last year.
- Addex Therapeutics' Retained Earnings amounted to -$447.8 million in Q3 2025, which was down 1018.1% from -$430.8 million recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Retained Earnings registered a high of -$355.2 million during Q2 2022, and its lowest value of -$447.8 million during Q3 2025.
- For the 4-year period, Addex Therapeutics' Retained Earnings averaged around -$394.2 million, with its median value being -$394.8 million (2023).
- Per our database at Business Quant, Addex Therapeutics' Retained Earnings crashed by 1292.33% in 2023 and then soared by 523.36% in 2025.
- Addex Therapeutics' Retained Earnings (Quarter) stood at -$363.2 million in 2022, then decreased by 11.88% to -$406.3 million in 2023, then grew by 0.73% to -$403.4 million in 2024, then dropped by 11.03% to -$447.8 million in 2025.
- Its Retained Earnings was -$447.8 million in Q3 2025, compared to -$430.8 million in Q2 2025 and -$394.7 million in Q1 2025.